EP3116902

CELLECTIS
Application Number
EP15709185A
Filing Date
Mar 11, 2015
Status
Granted And Under Opposition
Dec 5, 2019
Grant Date
Jan 1, 2020
External Links
Slate, Register

Biblio Summary

The patent EP3116902B1 was granted on Jan 1, 2020 by Cellectis The patent is currently Granted And Under Opposition.

The table below shows 4 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

CENTURY THERAPEUTICS, LLCOct 1, 2020ADMISSIBLE
EUROPEAN OPPOSITIONS LIMITEDOct 1, 2020ADMISSIBLE
JAMES POOLE LIMITEDOct 1, 2020ADMISSIBLE
WEINZIERL, GERHARDOct 1, 2020ADMISSIBLE

The table below shows the patents of Cellectis that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP2997141Cd19 Specific Chimeric Antigen Receptor And Uses ThereofOct 12, 20221
EP3189073Trophoblast Glycoprotein (5T4, Tpbg) Specific Chimeric Antigen Receptors For Cancer ImmunotherapyDec 25, 20191
EP3126390Cd33 Specific Chimeric Antigen Receptors For Cancer ImmunotherapyOct 16, 20191